NCT01518257 - Safety and Efficacy Study of Botulinum Toxin Type A as Treatment for Osteoarthritis Knee Pain | Biotech Hunter

Enrollment

121

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Osteoarthritis

Interventions

BIOLOGICAL

botulinum toxin Type A

A single 200U (2 mL) dose of botulinum toxin Type A injected into the intra-articular space of the study knee on Day 1.

DRUG

Normal Saline

A single 2 mL dose of Normal Saline (placebo) injected into the intra-articular space of the study knee on Day 1.

Trial Locations (1)

Aalborg